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Abstract: Dominant Optic Atrophy is a neuro-ophthalmic disease characterized by the
degeneration of the optic nerves. As other neurodegenerative diseases, this pathology was
associated with dysfunctional mitochondrial respiratory complexes and an increased production
of Reactive Oxygen Species (ROS). Our objective is to create a mathematical model of the
molecular mechanisms involved in the pathogenesis of Dominant Optic Atrophy in order
to predict their evolution and give appropriated treatment based on in-silico analysis with
physiological parameters from a specific patient. The first part of the work presented here
concerns processes and feedback mechanisms of the whole dysfunctional mitochondrial system.
The behaviour of the system is explained with a block diagram. In the second part, we present a
detailed stochastic model of catalytic activity and ROS production of respiratory complex I. We
developed the model using a Petri net formalism and a continuous-time Markov chains theory.
The simulations were realized on Matlab and compared to kinetic data from the literature. Our
model is able to reproduce the dynamics of the complex I system and to simulate observed
behaviours of this system regarding ROS production.
Keywords: Biological systems; Computer simulation; Markov models; Stochastic Petri-nets;
Stochastic modelling
INTRODUCTION
Neurodegenerative diseases are a major issue of public
health. Among these pathologies, neuro-ophthalmic con-
ditions including glaucoma, which affects 80 millions of
patients worldwide, but also genetic neurodegeneration of
the retina as in Dominant Optic Atrophy (DOA), are cen-
tral questions of our societies. Although mutations in the
nuclear gene OPA1 have been identified as the main cause
of DOA, the physio-pathological mechanisms involved are
still unknown and there is no therapy to date.
DOA is characterized by moderate to severe loss of visual
acuity with insidious onset in early childhood. The dis-
ease primarily affects the retinal ganglionic cells (RGC)
resulting in optic nerve atrophy. There is a consider-
able inter- and intra-familial variation in visual acuity
(Votruba et al., 1998), and the penetrance may be as low
as about 40% (Toomes et al., 2001). Estimated disease
prevalence is between 1:10,000 in Denmark and 1:50,000
worldwide. The majority of patients (about 75%) with
DOA harbors mutation in the OPA1 gene (Delettre et al.,
2000) which usually results in the reduction in OPA1 pro-
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tein levels. Interestingly, recent studies evidenced a severe
multi-systemic disorder associated with some OPA1 muta-
tions, named DOA plus syndrome (Amati-Bonneau et al.,
2008). Patients present additional neurological complica-
tions in adult life, including ataxia, sensorineural deaf-
ness, chronic progressive external ophtalmoplegia, sensory-
motor neuropathy and myopathy . These observations are
of major pathophysiological importance, highlighting the
widespread deleterious consequences of OPA1 mutations,
not only for RGCs, but also for other neuronal populations
and skeletal muscle. Glaucoma was also clearly related to
OPA1 gene status (Ju et al., 2010) with patients presenting
downregulation of its expression (Bosley et al., 2011).
The OPA1 gene encodes a mitochondrial protein localized
in the inter-membrane space and anchored to mitochon-
drial inner membrane which has various functions, includ-
ing inner membrane fusion, cristae structuration, mtDNA
maintenance, protection from apoptosis and mitochondrial
energetics modulation (Landes et al., 2010). The general
impact of OPA1 inactivation on mitochondrial energetics
modulation was investigated by Bertholet et al. and Millet
et al. in cellular models (rat cortical neurons and HeLa
cells), in OPA1enu/+ mice and in fibroblasts from DOA
and DOA+ patients. In both cellular models (HeLa cells
and cortical neurons), complex I, complex III and complex
IV are impaired and cellular respiration is diminished
when OPA1 is decreased (Bertholet et al., 2013). This
is accompanied by an increase in mitochondrial Reactive
Oxygen Species (ROS) production, which is buffered by
the activation of antioxidant defences. However, this sit-
uation leads to a pro-oxidative state, since further acute
or chronic exogenous oxidative stress challenged both the
antioxidant response and the viability of OPA1 depleted
neurons. Interestingly, some patients showed altered ex-
pression of genes implicated in the antioxidant machinery
(Millet et al., 2016). The authors proposed that muta-
tions or decreased quantity of OPA1 induce an imbalance
in the cellular redox state, weakening cells to exogenous
pro-oxidative stresses and leading to late onset apoptotic
death, that thus could be prevented.
Our objective is to create a mathematical model of the
molecular mechanisms involved in Dominant Optic Atro-
phy (DOA) and glaucoma, based on these assumptions,
in order to predict their evolution and give appropriated
treatment based on in-silico analysis with physiological
parameters for a specific patient. This paper is divided into
three sections and a conclusion. The first part provides a
description of the hypothesized molecular mechanisms and
the components to consider in the model. The second part
focuses on the ROS production of mammalian complex
I. The third part describes the model and techniques we
used to model complex I and the first results. Finally, the
ongoing work will be outlined in the conclusion.
1. SYSTEM MODEL OF MITOCHONDRIAL
(DYS)FUNCTIONS
Mitochondrial processes are central to the control of over-
all cell metabolism. However, the large number of interact-
ing reactions and pathways involving mitochondrial sub-
systems together with limited experimental observations
makes it very challenging to understand and model the
dynamics of this complex system. For this reason, we used
a block diagram to describe the possible behaviour of
this system in the context of DOA (fig.1). This formalism
aims at determining which processes and subsystems are
of interest in developing a better understanding of sys-
tem interactions and creating a model of DOA molecular
mechanisms.
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Fig. 1. Block diagram of mitochondrial systems inter-
actions in Dominant Optic Atrophy. MRC, Mito-
chondrial Respiratory Chain; ROS, Reactive Oxygen
Species; AntiOx, Antioxidants; mtDNA, mitochon-
drial DNA.
The oxidative phosphorylation is an essential part of the
mitochondrial energetic metabolism. It consists of five
enzyme complexes that are located in the inner mitochon-
drial membrane. Four of them (complexes I-IV) compose
the mitochondrial respiratory chain (MRC) or electron
transport chain whose function is to establish an elec-
trochemical proton gradient over this membrane and the
fifth complex, the F1Fo-ATPsynthase uses the force of this
gradient for the phosphorylation of adenosin-diphosphate
(ADP) to adenosin-triphosphate (ATP).
During a normal function of the MRC, ROS are basically
produced essentially by the first and third complexes.
However, complex I and complex III dysfunctions, caused
by genetic, environmental and pathological factors result
in a dramatic increase of their production of ROS.
ROS production by the dysfunctional respiratory chain
and their deleterious consequences are described in our
block diagram (fig.1).
These consequences comprise:
• protein oxidation (Stadman and Levine, 2000);
• lipid peroxidation (Halliwell and Chirico, 1993);
• mitochondrial DNA (mtDNA) mutations and dele-
tions (Richter et al., 1988).
All these processes result in a further dysfunction of the
MRC leading to reinforcing feedback loops, contributing
to cell death, that correspond to positive feedback loops
on the block diagram (fig.1):
• Respiratory complexes and proteins linked to their
well functioning are affected by mechanisms of protein
oxidation induced by ROS (Stadman and Levine,
2000);
• Lipid peroxidation has two consequences: structural
damage to membranes affecting the function of mem-
brane proteins including the MRC and generation
of secondary products. These products exhibit high
reactivity with proteins, mtDNA and lipids (Repetto
et al., 2010)
• The mtDNA encoded genes include seven subunits of
complex I, one subunit of complex III, three subunits
of complex IV and two subunits of complex V (Schon
et al., 2012). Therefore, accumulating mtDNA muta-
tions result in a decreased activity of the MRC and
an increased ROS production.
These deleterious consequences can be minimized un-
der the action of mtDNA repairing enzymes (Kazak
et al., 2012) and ROS scavengers, including enzymes and
quenchers (Halliwell and Gutteridge, 1999). These balanc-
ing actions correspond to the two negative feedback loops
of the block diagram (fig.1). However, these balancing
actions have a limited extent as Millet et al. observed in the
context of DOA (Millet et al., 2016) and can be saturated.
We first focused on the production of ROS by the MRC
in the development of our model and more particularly
on Complex I. ROS are derived from molecular oxygen
and superoxide anion O.–2 , the product of a one-electron
reduction of oxygen is the precursor of most ROS (Turrens,
2003). Complex I appears to be the primary source of O.–2
in the brain under normal conditions and in a variety of
pathological scenarios ranging from ageing to Parkinson’s
disease (Turrens, 2003).
2. COMPLEX I MECHANISMS
2.1 Structure and function
The role of Complex I is to oxidize NADH to NAD+,
reduce ubiquinone (Q) to ubiquinol (QH2) and translocate
four protons across the inner membrane of the mitochon-
dria to create a proton-motive force. Complex I from
Bos Taurus heart mitochondria is the most studied mam-
malian complex I (Hirst and Roessler, 2016) and comprises
45 proteins among which 14 conserved ‘core’ units are suf-
ficient to catalyse energy transduction (Fiedorczuk et al.,
2016). These 14 subunits are divided into a hydrophilic
redox domain and a hydrophobic domain contained in
the mitochondrial inner membrane (fig.2) and involved in
protons translocation (Fiedorczuk et al., 2016).
NADH is oxidized by a non-covalently bound flavin
mononucleotide (FMN) at the top of the hydrophilic do-
main. It almost certainly occurs by hydride transfer (single
step transfer of 2 electrons and one proton from NADH to
FMN) (Hirst and Roessler, 2016).
The fully reduced flavin FMNH– and the semi-reduced
flavin FMNH. transfer these electrons one by one to a chain
of eight ironsulfur (FeS) clusters constituting the redox
centers of the Complex I. The last cluster of the chain is
the electron donor to the Q-binding site. It is generally
accepted that biological electron transfer is a process of
tunnelling (Moser et al., 1992). Electron paramagnetic
resonance (EPR) studies on complex I from Bos taurus re-
vealed an alternating profile of higher and lower potential
clusters (Bridges et al., 2012). The alternating potentials
could contribute to the fast transfer of electrons and act
as a dynamic waiting queue for electrons, to synchronize
the different processes occurring in the complex I.
2.2 ROS production
Kinetic studies showed that the fully reduced flavin is
the electron donor to molecular oxygen and that an
increase in NADH concentration induces an increase of
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Fig. 2. Complex I mechanism. Adapted from (Vinothku-
mar et al., 2014)
ROS production (Kussmaul and Hirst, 2006), while a
further increase in NADH buffers this ROS production
(Birrell et al., 2009). NAD+ inhibits ROS production even
at low concentrations. Finally, while quinol favours the
increase in ROS due to a blockage of complex I, addition
of quinone buffers it (Kussmaul and Hirst, 2006).
2.3 Existing models and their limits
Black box models of complex I failed to describe its func-
tioning. Indeed, recently, it was shown that the kinetics of
Complex I do not obey a ping-pong mechanism as it was
assumed to, due to a strong spatial separation of NADH
oxidation and Q reduction and the presence of the iron-
sulfur cluster chain between NADH- and Q-binding sites
(Ransac et al., 2012). Electrons do not simply transfer
across the chain but jump back and forth depending on
the states of the closest redox centres and the probability
of electrons tunnelling.
A detailed stochastic model of complex I was consequently
proposed (Ransac et al., 2012). However, this model does
not simulate the production of ROS by Complex I. More-
over, the alternating profile of potentials observed in mam-
malian complex I (Bridges et al., 2012) was not considered
for the calculations of electron tunnelling probabilities
between iron-sulfur clusters. In addition, the probability
of reverse transfer between flavin and NAD+ might have
been overestimated: all the steps of the simulations were
used by the electrons exchange between the flavin and
NADH/NAD+. Besides it is likely that the interconversion
of NADH and NAD+ is thermodynamically not reversible.
It requires the application of an important driving force.
Finally, only the binding constants of the substrates were
adjusted and with limited kinetic data regarding the effects
of the different substrates on Complex I activity.
In contrast, we propose a detailed stochastic model of
Complex I which:
• includes the alternating profile of iron-sulfur clusters
potentials
• considers a non thermodynamical reversibility of the
hybrid electron proton transfer from NADH to the
flavin
• includes ROS production by Complex I in the form
of O.–2 .
3. COMPLEX I MODEL
We modelled the complex I as a stochastic Petri net (SPN),
taking into account the alternating profile of potentials
of the iron-sulfur clusters and a reasonable rate for the
reverse reaction between FMN and NADH to estimate the
transition probabilities and we simulated the net using a
Gillespie algorithm.
3.1 Petri net modelling description
The Petri net modelling the redox mechanism of Complex I
is represented in fig.3. It is composed of 11 places which can
contain the number of tokens indicated between brackets.
The tokens represent the electrons. The places whose name
start with N correspond to the iron-sulfur clusters. Cluster
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Fig. 3. Petri net model of Complex I
N1a is not included in the model since it cannot be reduced
by NADH (Bridges et al., 2012).
To simulate the net, we consider an equivalence between
the different number of tokens a place can contain and the
associated set of different chemical species. For instance,
the flavin place can contain 0, 1 or 2 electrons: this
respectively corresponds to the oxidized flavin FMN, the
semi-reduced flavin FMNH. and the fully reduced flavin
FMNH–.
The objective is to simulate evolution of their respective
number of molecules. The numbers of molecules of the
substrates and of O.–2 are not constrained. In contrast, the
other species can be represented only by one or zero copy
since there are only one of each cluster and one flavin
center in one complex I. Moreover, they cannot coexist:
for instance we have N5 or N5– for a given state of the
system but we cannot have both at the same time. We
assume that the semiquinone SQ which is the intermediate
between the first step and the second step of Q reduction
does not dissociate and hence can exist in only one copy.
We also take into account the binding and dissociation of
the substrates and consider that the protons translocation
occurs simultaneously with the reduction of Q.
We note the vector of different chemical species [S1, ..., SN]
and the vector of their respective number of molecules
[X1, ..., XN]. The firing of a transition corresponds to a
chemical reaction: the weights of the Petri net are therefore
determined by the stoichiometry of the reaction taking
place during the corresponding transition. We note the
vector of reaction channels [R1, ..., RM].
3.2 Probability rate constants calculation
We use the formalism proposed by Gillespie in his con-
struction of a stochastic simulation algorithm for chemical
systems (Gillespie, 1992) and note Πμ(t, dt) the probabil-
ity that a randomly selected combination of Rμ, reactant
molecules at time t will react accordingly in the next
infinitesimal time interval [t, t + dt). Biological electron
transfers fall within a context in which this probability
can be modelled as linearly dependent on dt (Moser and
Dutton, 1996; Gillespie, 1994). For each reaction channel
Rμ:
Πμ = cμdt (1)
where cμ is independent of dt. We call cμ the probability
rate constant for reaction channel Rμ.
Based on experimental measurements and the Marcus
theory of electron transfer, Moser et al. (Moser et al., 1992)
derived an empirical relation between the rate of exergonic
intraprotein electron transfer and the spatial separation
between electron donor and acceptor, which has proved to
be successful for distances above 4 A˚ (Moser et al., 2008):
log(kexer) = 15 – 0.6D – 3.1
(ΔG + λ)2
λ
(2)
Where, D is the edge-to-edge donor-acceptor distance in
A˚, ΔG is the driving force of the reaction in eV and λ
is the the reorganization energy required to change the
nuclear coordinates upon electron transfer. For endergonic
reactions they proposed a penalty term (Page et al., 1999)
(ΔG is negative for an exergonic reaction):
log(kender) = log(kexer) +
ΔG
0.06
(3)
The values for the driving forces are approximated us-
ing the differences of potentials measured in EPR stud-
ies (Bridges et al., 2012). The values for the distances
are taken from crystallographic studies(Fiedorczuk et al.,
2016). Finally, we used the value λ = 0.7 eV proposed by
Moser et al. on an empirical basis (Moser et al., 1992).
Concerning the reaction between NADH and the flavin,
it involves the transfer of a proton which is nearly 2000
times heavier than an electron and occurs at a distance
inferior to 4 A˚. For this reason we do not use the previous
relations to estimate this probability rate. We assume that
the proton transfer will be the limiting aspect of this
transfer and estimate its rate by calculating its velocity
under the acceleration of the electric field created by
the chemical species and multiplying it by the distance
between NADH and FMN. The electrical field is assumed
to be constant and estimated considering the difference of
potentials between the two species and a distance of 3.2
A˚ (Berrisford and Sazanov, 2009) between the flavin and
NADH. The value used for proton mobility is 3.2 ∗ 10–3
cm2.V–1.s–1. The rate obtained is of order 1012 s–1.
We assume that the reverse transfer is possible but only
under the application of an external driving force: under
normal conditions, the local conformation around the
flavin could be modified in the presence of NADH and
not NAD+ (observed on bacterial complex I (Mamedova
et al., 2004) ). For this reason the rate of the reverse inverse
is very small compared to the rate of forward transfer (of
order 102 – 103). We applied the same reasoning to the
reversibility of transfer between N2, this time for probable
local conformational changes under proton translocation
and protonation of Q.
3.3 Simulation algorithm
The linear-dt transition probabilities of the model allow to
simulate the SPN model of complex through its underlying
Continous-Time Markov Chain and to use the Gillespie
algorithm to this purpose (Gillespie, 1992).
We consider: hμ(n1, ..., nn) the number of distinct com-
binations of Rμ reactant molecules at time t when there
are exactly ni of the Si molecules; and p(τ, μ/n, t)dτ the
probability that, given X(t) = n, the next reaction in
the system will occur in the infinitesimal time interval
[t + τ, t + τ + dτ), and will be an Rμ reaction. It can be
shown (Gillespie, 1992) that:
p(τ, μ/n, t) = a(n) exp(–a(n)τ)
cμhμ(n)
a(n)
(4)
where a(n) =
∑N
μ=1 cμhμ(n).
Given X(t) = n, the ‘time to the next reaction’ and the
‘index of the next reaction’ are statistically independent
random variables, the former having the exponential den-
sity function with decay constant a(n), and the latter
having the integer density function
cμhμ(n)
a(n)
.
It can be shown (Gillespie, 1992) that we can generate
a statistically exact sample pair (τ, μ) according to this
joint density function by first generating two unit-interval
uniform random numbers r1 and r2, then taking τ to be:
τ =
1
a(n)
ln(
1
r1
) (5)
and taking μ to be the smallest integer for which:
μ∑
m=1
cmhm(n) > r2a(n) (6)
Finally, the algorithm used to simulate the Petri net takes
the following form (Gillespie, 1977):
1: Input the desired values for the M reaction constants
[c1, ..., cM] and the N initial molecular population
numbers [X1, ..., XN]. Set tmax, t = 0.
2: while t ≤ tmax do
3: Calculate and store aμ = hμcμ for μ = 1, ..., M and
a0 =
∑M
μ=1 aμ.
4: Generate two random numbers r1 and r2, using a
unit-interval uniform random number generator, and
calculate (τ, μ) based on equations 5 and 6 .
5: Adjust Xi to reflect the occurrence of the Rμ reaction.
6: Put t = t + τ.
7: end while
3.4 Comparison to experimental data
The fixed parameters in the relationships derived by Moser
et al. (Moser et al., 1992) are average parameters for redox
proteins (Page et al., 1999). We first considered other
possible fixed parameters values and used a tabu search
algorithm for the binding and dissociation constants, to fit
the results of our numerical simulations with experimental
data from the literature (Sherwood and Hirst, 2006). Then
we fitted the value of the probability rate constant for O.–2
formation using data from (Kussmaul and Hirst, 2006).
4. RESULTS
Fig.4a shows the simulated reduction of 100 μM Q by 100
μM NADH catalysed by 15 mg.ml–1 Complex I without O2
compared to experimental data in (Sherwood and Hirst,
2006). Fig.4b and fig.4c show the simulated dependence
of O.–2 production on [NADH] compared to experimental
data in (Kussmaul and Hirst, 2006). At low concentrations
of NADH the rate of O.–2 is almost independent of NADH
with a very slight increase until 3 μM of NADH. At higher
concentrations NADH exerts an inhibitory effect on O.–2
production. Fig.4d shows the simulated linear dependence
of O.–2 production on O2 concentration (% saturated in
air) at 30 μM NADH compared to experimental data in
(Kussmaul and Hirst, 2006).
(a)
(b)
(c)
(d)
Fig. 4. Computer simulations of Complex I catalytic ac-
tivity and ROS production compared to experimental
data taken from (Sherwood and Hirst, 2006) and
(Kussmaul and Hirst, 2006). In (b) to (d) Vros stands
for the rate of formation of O.–2 in nmol/min/mg of
Complex I.
5. DISCUSSION
We have developed a stochastic model able to reproduce
the dynamics of mitochondrial complex I and to simulate
its production of O.–2 under certain conditions . However,
measurements of O.–2 concentrations are usually done using
indirect methods and, are prone to uncertainty and a high
variability. For instance, the approximate rate measured in
fig.4c at 30 μM NADH and 100% O2 saturation is different
from the rate measured in fig.4d under the same conditions
(respectively 50 nmol/min/mg and 30 nmol/min/mg). The
value of the probability rate constant for O.–2 formation
was fitted using data in fig.4c which explains the distance
between numerical and experimental data on fig.4d. This
highlights the need to incorporate uncertainty in our
model in order to reach our long term objective which
is to create a mathematical model of DOA able to predict
the evolution of the disease for a specific patient and to
give a personalized treatment.
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